
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Colon Cancer Pharmacogenetics: A Narrative Review
Álvaro Esteban Alfaro Alfaro, Brayan Murillo Castillo, Eugenia Cordero García, et al.
Pharmacy (2022) Vol. 10, Iss. 4, pp. 95-95
Open Access | Times Cited: 12
Álvaro Esteban Alfaro Alfaro, Brayan Murillo Castillo, Eugenia Cordero García, et al.
Pharmacy (2022) Vol. 10, Iss. 4, pp. 95-95
Open Access | Times Cited: 12
Showing 12 citing articles:
Atorvastatin calcium alleviates 5-fluorouracil-induced intestinal damage by inhibiting cellular senescence and significantly enhances its antitumor efficacy
Jing Xia, Siyue He, Qianlong Dai, et al.
International Immunopharmacology (2023) Vol. 121, pp. 110465-110465
Closed Access | Times Cited: 25
Jing Xia, Siyue He, Qianlong Dai, et al.
International Immunopharmacology (2023) Vol. 121, pp. 110465-110465
Closed Access | Times Cited: 25
The Pivotal Role of the Gut Microbiome in Colorectal Cancer
Ruqaiyyah Siddiqui, Anania Boghossian, Ahmad M. Alharbi, et al.
Biology (2022) Vol. 11, Iss. 11, pp. 1642-1642
Open Access | Times Cited: 22
Ruqaiyyah Siddiqui, Anania Boghossian, Ahmad M. Alharbi, et al.
Biology (2022) Vol. 11, Iss. 11, pp. 1642-1642
Open Access | Times Cited: 22
Fe3O4 Nanoparticles in Combination with 5-FU Exert Antitumor Effects Superior to Those of the Active Drug in a Colon Cancer Cell Model
Sıdıka Genç, Ali Taghizadehghalehjoughi, Yeşim Yeni, et al.
Pharmaceutics (2023) Vol. 15, Iss. 1, pp. 245-245
Open Access | Times Cited: 10
Sıdıka Genç, Ali Taghizadehghalehjoughi, Yeşim Yeni, et al.
Pharmaceutics (2023) Vol. 15, Iss. 1, pp. 245-245
Open Access | Times Cited: 10
SNHG4-mediated PTEN destabilization confers oxaliplatin resistance in colorectal cancer cells by inhibiting ferroptosis
Siqi Li, Wenting Xu, Yixin Yin, et al.
APOPTOSIS (2024) Vol. 29, Iss. 5-6, pp. 835-848
Closed Access | Times Cited: 3
Siqi Li, Wenting Xu, Yixin Yin, et al.
APOPTOSIS (2024) Vol. 29, Iss. 5-6, pp. 835-848
Closed Access | Times Cited: 3
An empirical review on the resistance mechanisms of epidermal growth factor receptor inhibitors and predictive molecular biomarkers in colorectal cancer
Sankha Bhattacharya
Critical Reviews in Oncology/Hematology (2023) Vol. 183, pp. 103916-103916
Closed Access | Times Cited: 9
Sankha Bhattacharya
Critical Reviews in Oncology/Hematology (2023) Vol. 183, pp. 103916-103916
Closed Access | Times Cited: 9
How the interplay among the tumor microenvironment and the gut microbiota influences the stemness of colorectal cancer cells
María Belén Novoa Díaz, Pedro Carriere, Claudia Gentili
World Journal of Stem Cells (2023) Vol. 15, Iss. 5, pp. 281-301
Open Access | Times Cited: 9
María Belén Novoa Díaz, Pedro Carriere, Claudia Gentili
World Journal of Stem Cells (2023) Vol. 15, Iss. 5, pp. 281-301
Open Access | Times Cited: 9
A Novel EGFR Targeted Immunotoxin Based on Cetuximab and Type 1 RIP Quinoin Overcomes the Cetuximab Resistance in Colorectal Cancer Cells
Nicola Landi, Vincenza Ciaramella, Sara Ragucci, et al.
Toxins (2023) Vol. 15, Iss. 1, pp. 57-57
Open Access | Times Cited: 4
Nicola Landi, Vincenza Ciaramella, Sara Ragucci, et al.
Toxins (2023) Vol. 15, Iss. 1, pp. 57-57
Open Access | Times Cited: 4
Elucidating the Mechanism of Agrimonolide in Treating Colon Cancer Based on Network Pharmacology
Lei Yu, Yun Gai
Drug Design Development and Therapy (2023) Vol. Volume 17, pp. 2209-2222
Open Access | Times Cited: 4
Lei Yu, Yun Gai
Drug Design Development and Therapy (2023) Vol. Volume 17, pp. 2209-2222
Open Access | Times Cited: 4
HSPB6 Is Depleted in Colon Cancer Patients and Its Expression Is Induced by 5-aza-2′-Deoxycytidine In Vitro
Bader O. Almutairi, Mikhlid H. Almutairi, Abdulwahed Fahad Alrefaei, et al.
Medicina (2023) Vol. 59, Iss. 5, pp. 996-996
Open Access | Times Cited: 3
Bader O. Almutairi, Mikhlid H. Almutairi, Abdulwahed Fahad Alrefaei, et al.
Medicina (2023) Vol. 59, Iss. 5, pp. 996-996
Open Access | Times Cited: 3
LAMP2A overexpression in colorectal cancer promotes cell growth and glycolysis via chaperone‑mediated autophagy
Rui Chen, Yanfei Zhang, Yuanxun Ge, et al.
Oncology Letters (2023) Vol. 27, Iss. 1
Open Access | Times Cited: 3
Rui Chen, Yanfei Zhang, Yuanxun Ge, et al.
Oncology Letters (2023) Vol. 27, Iss. 1
Open Access | Times Cited: 3
Explanatory Role of Conversion Surgery as a Mediator of the Mortality Risk Difference Between Patients With Unresectable Metastatic Colorectal Cancer Treated With First-Line Anti-EGFR Agents Versus Bevacizumab
Chien‐Chou Su, Yi‐Chia Su, Chih‐Chien Wu, et al.
Clinical Colorectal Cancer (2024) Vol. 23, Iss. 4, pp. 364-371
Closed Access
Chien‐Chou Su, Yi‐Chia Su, Chih‐Chien Wu, et al.
Clinical Colorectal Cancer (2024) Vol. 23, Iss. 4, pp. 364-371
Closed Access
Antitumoral effect thought ROS production of the sesquiterpene lactone centratherin isolated from Eremanthus crotonoides , an endemic plant from Brazil
Francisco Paiva Machado, Guilherme Freimann Wermelinger, Alex de Souza Cruz Lopes Canuto, et al.
Natural Product Research (2024), pp. 1-8
Open Access
Francisco Paiva Machado, Guilherme Freimann Wermelinger, Alex de Souza Cruz Lopes Canuto, et al.
Natural Product Research (2024), pp. 1-8
Open Access